<!DOCTYPE html>
<html lang="en">
<head>
  <!-- Google tag (gtag.js) -->
  <script async src="https://www.googletagmanager.com/gtag/js?id=G-LSRR4KW715"></script>
  <script>
    window.dataLayer = window.dataLayer || [];
    function gtag(){dataLayer.push(arguments);}
    gtag('js', new Date());

    gtag('config', 'G-LSRR4KW715');
  </script>


  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>Case 7.5 - Cystic Fibrosis [SDL] | MD3 SCP Cases</title>

  <!-- Favicon -->
  <link rel="icon" type="image/png" href="../assets/ShepTech logo.png">
  <link rel="apple-touch-icon" href="../assets/ShepTech logo.png">

  <!-- Primary Meta Tags -->
  <meta name="title" content="Case 7.5 - Cystic Fibrosis [SDL] | MD3 SCP Cases">
  <meta name="description" content="Self-directed learning case on cystic fibrosis for medical students.">

  <!-- Open Graph / Facebook -->
  <meta property="fb:app_id" content="your_facebook_app_id">
  <meta property="og:type" content="article">
  <meta property="og:url" content="https://md3-scp.netlify.app/cases/case7_5.html">
  <meta property="og:title" content="Case 7.5 - Cystic Fibrosis [SDL]">
  <meta property="og:site_name" content="MD3 SCP Cases">
  <meta property="og:description" content="Self-directed learning case on cystic fibrosis for medical students.">
  <meta property="og:image" content="https://md3-scp.netlify.app/assets/ShepTech%20logo.png">

  <!-- Twitter -->
  <meta property="twitter:card" content="summary">
  <meta property="twitter:title" content="Case 7.5 - Cystic Fibrosis [SDL]">
  <meta property="twitter:description" content="Self-directed learning case on cystic fibrosis for medical students.">
  <meta property="twitter:image" content="https://md3-scp.netlify.app/assets/ShepTech%20logo.png">

  <link rel="stylesheet" href="../css/case.css">

  <!-- Firebase SDK -->
  <script src="https://www.gstatic.com/firebasejs/9.22.0/firebase-app-compat.js"></script>
  <script src="https://www.gstatic.com/firebasejs/9.22.0/firebase-auth-compat.js"></script>
  <script src="https://www.gstatic.com/firebasejs/9.22.0/firebase-firestore-compat.js"></script>
</head>
<body>
  <div class="container">
    <div class="case-header">
      <a href="#" class="back-link" onclick="goBack(event)">← Back to Cases</a>
    </div>

    <h1>Case 7.5 – Cystic Fibrosis [SDL]</h1>
    <p class="meta"><strong>Category:</strong> Respiratory System | <strong>Discipline:</strong> Medicine | <strong>Setting:</strong> Emergency Department</p>

    <h2>Case</h2>
    <p>Michael Seaver, aged 18 years has cystic fibrosis and presents to the emergency department with a flare up of the usual. He is worried as last time he cultured a resistant organism and required triple therapy.</p>

    <h2>Questions</h2>

    <div class="question">
      <strong>1. What further history and examination would you undertake?</strong><br>
      <button class="toggle">Show Answer</button>
      <div class="answer">
        <p>A correlation may be made between the mutation and the patient's clinical condition. Based on current knowledge of the association between genotype and phenotype, the clinical characteristics of patients with cystic fibrosis (CF) are divided into severe, milder than severe, and variable phenotypes.</p>

        <p><strong>The affected organs include:</strong></p>

        <p><strong>Respiratory tract:</strong></p>
        <ul>
          <li>Ask about cough, chronic or recurrent cough, which can be dry and hacking at the beginning and later mucoid (early) and purulent (later) sputum</li>
          <li>Other respiratory symptoms may include wheezing, recurrent pneumonia, atypical asthma, pneumothorax, hemoptysis, and digital clubbing are all complications and may be the initial manifestation</li>
          <li>Check for increasing shortness of breath</li>
        </ul>

        <p><strong>Pancreatic dysfunction:</strong></p>
        <ul>
          <li>Check for use of pancreatic supplements and the adequacy of replacement</li>
          <li>Steatorrhea is characterized by frequent, poorly formed, large, bulky, foul-smelling, greasy stools that float in water</li>
          <li>Check for weight loss, recurrent abdominal pain, and abdominal distention</li>
        </ul>

        <p><strong>Hepatobiliary:</strong></p>
        <ul>
          <li>Check for symptoms of biliary dysfunction such as nausea, vomiting, dark urine, bleeding</li>
          <li>Patients may present with a history of jaundice or gastrointestinal tract bleeding</li>
        </ul>

        <p><strong>Urogenital tract manifestations:</strong></p>
        <ul>
          <li>Males are frequently sterile because of the absence of the vas deferens</li>
          <li>Undescended testicles or hydrocele may exist</li>
        </ul>

        <p><strong>Physical examination includes:</strong></p>
        <ul>
          <li><strong>Nose:</strong> Rhinitis, nasal polyps</li>
          <li><strong>Respiratory system:</strong> Tachypnea, degree of distress, wheeze or crackles, cough, sputum, diameter of chest, clubbing, cyanosis, crackles</li>
          <li><strong>Gastrointestinal tract:</strong> Abdominal distention, hepatosplenomegaly, rectal prolapse</li>
        </ul>
      </div>
    </div>

    <div class="question">
      <strong>2. What are the complications of cystic fibrosis?</strong><br>
      <button class="toggle">Show Answer</button>
      <div class="answer">
        <p><strong>Respiratory:</strong></p>
        <ul>
          <li>Infective exacerbations of bronchiectasis</li>
          <li>Spontaneous pneumothorax</li>
          <li>Haemoptysis</li>
          <li>Nasal polyps</li>
          <li>Respiratory failure</li>
          <li>Cor pulmonale</li>
          <li>Lobar collapse due to secretions</li>
        </ul>

        <p><strong>Gastrointestinal:</strong></p>
        <ul>
          <li>Malabsorption and steatorrhoea</li>
          <li>Distal intestinal obstruction syndrome</li>
          <li>Biliary cirrhosis and portal hypertension</li>
          <li>Gallstones</li>
        </ul>

        <p><strong>Others:</strong></p>
        <ul>
          <li>Diabetes (25% of adults)</li>
          <li>Delayed puberty</li>
          <li>Male infertility</li>
          <li>Stress incontinence</li>
          <li>Psychosocial problems</li>
          <li>Osteoporosis</li>
          <li>Arthropathy</li>
        </ul>
      </div>
    </div>

    <div class="question">
      <strong>3. What are the clinical features of cystic fibrosis?</strong><br>
      <button class="toggle">Show Answer</button>
      <div class="answer">
        <p>The lungs are macroscopically normal at birth, however bronchiolar inflammation and infections usually lead to bronchiectasis in childhood.</p>

        <p>The lungs become infected, most commonly with <em>Staphylococcus aureus</em>. Later, the majority of patients have <em>Pseudomonas aeruginosa</em> infection by the time they reach adolescence. Recurrent exacerbations of bronchiectasis, initially in the upper lobes but subsequently throughout both lungs, cause progressive lung damage resulting ultimately in death from respiratory failure.</p>

        <p>Other clinical manifestations of the gene defect include intestinal obstruction, exocrine pancreatic failure with malabsorption, diabetes and hepatic cirrhosis.</p>

        <p>Most men with CF are infertile due to failure of development of the vas deferens, but microsurgical sperm aspiration and in vitro fertilisation are now possible.</p>

        <p>The genotype is a poor predictor of severity of disease in most individuals; even siblings with matching genotypes may have quite different phenotypes. This suggests that other 'modifier genes' (as yet unidentified) influence clinical outcome.</p>
      </div>
    </div>

    <div class="question">
      <strong>4. How would you manage this case?</strong><br>
      <button class="toggle">Show Answer</button>
      <div class="answer">
        <p><strong>Chest physiotherapy:</strong></p>
        <p>Regular chest physiotherapy is essential to maintain airway clearance.</p>

        <p><strong>Treat infections:</strong></p>
        <ul>
          <li>While infections with <em>Staph. aureus</em> can often be managed with oral antibiotics, intravenous treatment is needed for <em>Pseudomonas</em> species</li>
          <li>Nebulised antibiotic therapy, mainly with colomycin or tobramycin is used between exacerbations in an attempt to suppress chronic <em>Pseudomonas</em> infection</li>
          <li>Unfortunately, the bronchi of many CF patients eventually become colonised with pathogens which are resistant to most antibiotics</li>
          <li>Resistant strains of <em>P. aeruginosa</em>, <em>Stenotrophomonas maltophilia</em> and <em>Burkholderia cepacia</em> are the main culprits, and may require prolonged treatment with unusual combinations of antibiotics</li>
          <li><em>Aspergillus</em> and 'atypical mycobacteria' are also frequently found in the sputum of CF patients, but in most cases these behave as benign 'colonisers' of the bronchiectatic airways and do not require specific therapy</li>
        </ul>

        <p><strong>Treat co-incidental airways diseases:</strong></p>
        <p>Treat co-incidental airways diseases such as asthma if present.</p>

        <p><strong>Nebulised DNase:</strong></p>
        <ul>
          <li>Treatment with nebulised recombinant human deoxyribonuclease (DNase) has been available since 1994</li>
          <li>The aim of this is to liquify the sputum by breaking up the excess viscous DNA derived from disintegrated inflammatory cells</li>
          <li>Careful monitoring of response to treatment is appropriate as this treatment is very expensive</li>
        </ul>

        <p><strong>Non-respiratory aspects of CF must be considered:</strong></p>
        <ul>
          <li>There is a clear link between good nutrition and prognosis in CF</li>
          <li>Malabsorption is treated with oral vitamins and pancreatic enzyme supplements and the increased calorie requirements of CF patients are met by supplemental feeding including nasogastric or gastrostomy tube feeding if required</li>
          <li>Diabetes will eventually appear in about 25% of patients and often requires insulin therapy</li>
          <li>Osteoporosis secondary to malabsorption and chronic ill health should be sought and treated</li>
        </ul>

        <p><strong>Long term treatments:</strong></p>
        <ul>
          <li>For advanced CF lung disease, home oxygen and non-invasive ventilation may be necessary to treat respiratory failure</li>
          <li>Ultimately, lung transplantation can produce dramatic improvements but is limited by donor organ availability</li>
        </ul>
      </div>
    </div>

    <div class="question">
      <strong>5. What is the role of somatic gene therapy?</strong><br>
      <button class="toggle">Show Answer</button>
      <div class="answer">
        <p>The discovery of the CF gene and the fact that the lethal defect is located in the respiratory epithelium (which is accessible by inhaled therapy) presents an exciting opportunity for gene therapy.</p>

        <p>Manufactured normal CF gene can be 'packaged' within a viral or liposome vector and delivered to the respiratory epithelium to correct the genetic defect.</p>

        <p>Initial trials in the nasal and bronchial epithelium have shown some effect, and further trials of nebulised bronchial delivery are planned.</p>

        <p>Improved gene transfer efficiency is needed before this will become a practical clinical treatment.</p>
      </div>
    </div>

    <div class="question">
      <strong>6. Define the following terms used in respiratory medicine: FEV1, FVC, VC, PEF, TLC, FRC, RV, TLco, Kco.</strong><br>
      <button class="toggle">Show Answer</button>
      <div class="answer">
        <table style="width: 100%; border-collapse: collapse; margin-top: 10px;">
          <tr style="background-color: #f2f2f2;">
            <th style="border: 1px solid #ddd; padding: 8px; text-align: left;">Abbreviation</th>
            <th style="border: 1px solid #ddd; padding: 8px; text-align: left;">Stands for</th>
          </tr>
          <tr>
            <td style="border: 1px solid #ddd; padding: 8px;"><strong>FEV1</strong></td>
            <td style="border: 1px solid #ddd; padding: 8px;">Forced expiratory volume in 1 second</td>
          </tr>
          <tr style="background-color: #f9f9f9;">
            <td style="border: 1px solid #ddd; padding: 8px;"><strong>FVC</strong></td>
            <td style="border: 1px solid #ddd; padding: 8px;">Forced vital capacity</td>
          </tr>
          <tr>
            <td style="border: 1px solid #ddd; padding: 8px;"><strong>VC</strong></td>
            <td style="border: 1px solid #ddd; padding: 8px;">Vital capacity (relaxed)</td>
          </tr>
          <tr style="background-color: #f9f9f9;">
            <td style="border: 1px solid #ddd; padding: 8px;"><strong>PEF</strong></td>
            <td style="border: 1px solid #ddd; padding: 8px;">Peak (maximum) expiratory flow</td>
          </tr>
          <tr>
            <td style="border: 1px solid #ddd; padding: 8px;"><strong>TLC</strong></td>
            <td style="border: 1px solid #ddd; padding: 8px;">Total lung capacity</td>
          </tr>
          <tr style="background-color: #f9f9f9;">
            <td style="border: 1px solid #ddd; padding: 8px;"><strong>FRC</strong></td>
            <td style="border: 1px solid #ddd; padding: 8px;">Functional residual capacity</td>
          </tr>
          <tr>
            <td style="border: 1px solid #ddd; padding: 8px;"><strong>RV</strong></td>
            <td style="border: 1px solid #ddd; padding: 8px;">Residual volume</td>
          </tr>
          <tr style="background-color: #f9f9f9;">
            <td style="border: 1px solid #ddd; padding: 8px;"><strong>TLCO</strong></td>
            <td style="border: 1px solid #ddd; padding: 8px;">Gas transfer factor for carbon monoxide</td>
          </tr>
          <tr>
            <td style="border: 1px solid #ddd; padding: 8px;"><strong>KCO</strong></td>
            <td style="border: 1px solid #ddd; padding: 8px;">Gas transfer per unit lung volume</td>
          </tr>
        </table>
      </div>
    </div>
  </div>

<!-- JavaScript -->  <script src="../js/firebase-config.js"></script>
  <script src="../js/auth.js"></script>
  <script src="../js/completion-tracker.js"></script>
  <script src="../js/flag-tracker.js"></script>
  <script src="../js/case-interactions.js"></script>

  <script>
    // Toggle case completion
    function toggleCaseCompletion() {
      if (window.completionTracker) {
        const caseId = window.completionTracker.getCurrentCaseId();
        if (caseId) {
          window.completionTracker.toggleCompletion(caseId);
        }
      }
    }// Toggle case flag
    function toggleCaseFlag() {
      console.log('toggleCaseFlag() function called');
      console.log('window.flagTracker exists:', !!window.flagTracker);

      if (!window.flagTracker) {
        console.error('window.flagTracker is not defined!');
        alert('Flag tracker not initialized. Please refresh the page.');
        return;
      }

      const caseId = window.flagTracker.getCurrentCaseId();
      console.log('Current case ID:', caseId);

      if (!caseId) {
        console.error('Could not get case ID');
        alert('Could not determine case ID');
        return;
      }

      console.log('Calling window.flagTracker.toggleCaseFlag with caseId:', caseId);
      window.flagTracker.toggleCaseFlag(caseId);
    }

    // Update case flag button state on page load
    document.addEventListener('DOMContentLoaded', () => {
      if (window.flagTracker) {
        setTimeout(() => {
          const caseId = window.flagTracker.getCurrentCaseId();
          if (caseId) {
            window.flagTracker.updateCaseFlagButton(caseId);
          }
        }, 100);
      }
    });
    }
  </script>

</body>
</html>
